Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07828977
PHASE4

Effect of Neuromuscular Blockade on Video Laryngeal Mask Airway Ventilation

Sponsor: Korea University Guro Hospital

View on ClinicalTrials.gov

Summary

This prospective, randomized, double-blind study aims to evaluate the effect of different degrees of neuromuscular blockade on the performance of a video laryngeal mask airway (LMA) during general anesthesia. Participants will be randomly assigned to receive rocuronium at 0, 0.3, or 0.6 mg/kg, corresponding to 0, 1, or 2 times the ED95, respectively. The primary outcome is oropharyngeal leak pressure measured after LMA insertion. Secondary outcomes include LMA insertion conditions, insertion time and number of attempts, laryngeal view, respiratory parameters, and postoperative airway-related complications.

Official title: The Relationship Between the Degree of Neuromuscular Blockade and the Conditions of Laryngeal Mask Ventilation: A Prospective Randomized Double-Blind Study

Key Details

Gender

All

Age Range

20 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

96

Start Date

2026-09-07

Completion Date

2027-08-30

Last Updated

2026-09-18

Healthy Volunteers

No

Interventions

OTHER

Normal Saline (Rocuronium 0 mg/kg)

Normal saline is administered intravenously as the control study drug before video LMA insertion.

DRUG

Rocuronium 0.3 mg/kg

Rocuronium 0.3 mg/kg (1 × ED95) is administered intravenously before video LMA insertion.

DRUG

Rocuronium 0.6 mg/kg

Rocuronium 0.6 mg/kg (2 × ED95) is administered intravenously before video LMA insertion.